Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Salvage and RT vs No RT in Advanced Hodgkin's Lymphoma (HD0801)
NCT00784537Phase 3Completed
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Sep 2008
- Primary completion
- Jan 2015
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bleomycin + dacarbazine + doxorubicin + vinblastine in Hodgkin lymphoma (HL), sponsored by Fondazione Italiana Linfomi. Started Sep 2008; status: completed.
02
Drugs
bleomycin + dacarbazine + doxorubicin + vinblastine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00784537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00784537.